---
schema_version: "secwatch.filing_event.v1"
accession: "0001847903-22-000053"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2022-09-12T23:59:59+00:00"
generated_at: "2026-06-23T11:22:59.357570+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Centessa furnishes corporate presentation; no specific financial or operational updates

## Summary
- Presentation posted to Investor section of centessa.com as of September 12, 2022.
- No earnings, guidance, pipeline data, or other material disclosures included in the filing.
- Presentation contains standard corporate overview and forward-looking disclaimers only.

## SEC filing metadata
- accession: 0001847903-22-000053
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2022-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000184790322000053/0001847903-22-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000184790322000053/cnta-20220912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001847903-22-000053
- JSON: https://secwatch.observer/filing/0001847903-22-000053.json
- Plain text: https://secwatch.observer/filing/0001847903-22-000053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.